Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED)
| Autor: | Douglas M. Brodman, Boris Birmaher, John T. Walkup, John Piacentini, Philip C. Kendall, Joseph F. McGuire, Tara S. Peris, Dara Sakolsky, Satish Iyengar, Nicole E. Caporino, Golda S. Ginsburg |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Generalized anxiety disorder Adolescent Placebo Article law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Anxiety Separation Sertraline Outcome Assessment Health Care Developmental and Educational Psychology medicine Humans 0501 psychology and cognitive sciences Child Cognitive Behavioral Therapy Remission Induction 05 social sciences Separation anxiety disorder Phobia Social medicine.disease Anxiety Disorders 030227 psychiatry Psychiatry and Mental health Clinical Global Impression Anxiety Drug Therapy Combination Female medicine.symptom Psychology Selective Serotonin Reuptake Inhibitors 050104 developmental & child psychology medicine.drug Clinical psychology Coping Cat |
| Zdroj: | Journal of the American Academy of Child & Adolescent Psychiatry. 56:696-702 |
| ISSN: | 0890-8567 0005-2078 |
| DOI: | 10.1016/j.jaac.2017.05.018 |
| Popis: | Objective To determine optimal percent reduction and raw score cutoffs on the parent- and child-report Screen for Child Anxiety Related Emotional Disorders (SCARED) for predicting treatment response and remission among youth with anxiety disorders. Method Data were obtained from youth (N = 438; 7–17 years old) who completed treatment in the Child/Adolescent Anxiety Multimodal treatment Study, a multisite, randomized clinical trial that examined the relative efficacy of medication (sertraline), cognitive-behavioral therapy (Coping Cat), their combination, and pill placebo for the treatment of separation anxiety disorder, generalized anxiety disorder, and social phobia. The parent- and youth-report SCARED were administered at pre- and posttreatment. Quality receiver operating characteristic methods evaluated the performance of various SCARED percent reduction and absolute cutoff scores in predicting treatment response and remission, as defined by posttreatment ratings on the Clinical Global Impression scales and the Anxiety Disorders Interview Schedule. Results Reductions of 55% on the SCARED-Parent and 50% on the SCARED-Youth optimally predicted treatment response. Posttreatment absolute raw scores of 10 (SCARED-Parent) and 12 (SCARED-Youth) optimally predicted remission in the total sample, although separate SCARED-Parent cutoffs for children (12–13) and adolescents (9) showed greatest quality of efficiency. Each cutoff significantly predicted response and remission at 6-month follow-up. Conclusion Results serve as guidelines for operationalizing treatment response and remission on the SCARED, which could help clinicians systematically monitor treatment outcomes of youth with anxiety disorders in a cost- and time-efficient manner. Clinical trial registration information—Child and Adolescent Anxiety Disorders (CAMS); http://clinicaltrials.gov/ ; NCT00052078 . |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|